We are live on ! Find out more
RDUS

Radius Health, Inc.

Delisted

RDUS was delisted on the 12th of August, 2022.

131 hedge funds and large institutions have $891M invested in Radius Health, Inc. in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 47 increasing their positions, 43 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 43

6% less call options, than puts

Call options by funds: $4.8M | Put options by funds: $5.11M

7% less funds holding

Funds holding: 141131 (-10)

13% less capital invested

Capital invested by funds: $1.02B → $891M (-$134M)

43% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 23

Holders
131
Holders Change
-10
Holders Change %
-7.09%
% of All Funds
2.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
47
Reduced
43
Closed
23
Calls
$4.8M
Puts
$5.11M
Net Calls
-$301K
Net Calls Change
-$650K
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$145M +$316K +15,891 +0.2%
BG
2
Bellevue Group
Switzerland
$137M
Vanguard Group
3
Vanguard Group
Pennsylvania
$85M +$38.1K +1,917 +0%
BlackRock
4
BlackRock
New York
$66.7M -$4.9M -246,599 -6%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$60.7M -$6.59M -331,318 -9%
State Street
6
State Street
Massachusetts
$42.5M +$3.01M +151,558 +7%
FCM
7
Farallon Capital Management
California
$38.4M
Artisan Partners
8
Artisan Partners
Wisconsin
$29.4M +$52.4K +2,637 +0.2%
CCM
9
Camber Capital Management
Massachusetts
$27.4M
BNP Paribas Asset Management
10
BNP Paribas Asset Management
France
$22.7M +$1.32M +66,222 +6%
RCMNY
11
Rubric Capital Management (New York)
New York
$17.3M +$9.91M +498,348 +111%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$15.4M +$801K +40,289 +5%
Jacobs Levy Equity Management
13
Jacobs Levy Equity Management
New Jersey
$15M +$283K +14,236 +2%
Goldman Sachs
14
Goldman Sachs
New York
$10.2M +$1.71M +86,028 +18%
Northern Trust
15
Northern Trust
Illinois
$9.67M +$36.7K +1,844 +0.3%
Morgan Stanley
16
Morgan Stanley
New York
$8.45M +$348K +17,476 +4%
RPAM
17
Rhenman & Partners Asset Management
Sweden
$7.84M
CS
18
Candriam SCA
Luxembourg
$7.35M +$1M +50,501 +14%
N
19
Nuveen
North Carolina
$6.87M -$868K -43,658 -10%
Charles Schwab
20
Charles Schwab
California
$6.8M +$179K +9,018 +2%
Norges Bank
21
Norges Bank
Norway
$6.29M +$1.89M +95,200 +38%
Arrowstreet Capital
22
Arrowstreet Capital
Massachusetts
$6.28M +$924K +46,482 +16%
JAM
23
Jupiter Asset Management
United Kingdom
$6.26M +$65.7K +3,304 +1%
D.E. Shaw & Co
24
D.E. Shaw & Co
New York
$6.2M -$1.45M -72,963 -18%
New York State Common Retirement Fund
25
New York State Common Retirement Fund
New York
$5.91M +$503K +25,291 +8%

RDUS Hedge Fund Activity: Q2 2021 in Review

131 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Radius Health, Inc. (RDUS) for Q2 2021, worth a combined $891M — down 13% from $1.02B a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of RDUS and 13 opened new positions — a net loss of 10 holders — while 43 trimmed existing stakes and 47 added.

The largest buyer was Rubric Capital Management (New York), adding an estimated $9.91M. The largest seller was Wellington Management Group, cutting an estimated $6.59M.

  • 131 institutional investors held Radius Health, Inc. (RDUS) as of Q2 2021, down from 141 in Q1 2021.
  • Funds reported $891M of Radius Health, Inc. stock for Q2 2021, down 13% quarter-over-quarter.
  • 13 funds opened new Radius Health, Inc. positions in Q2 2021 and 23 closed out, a net change of -10 holders.
  • The largest Radius Health, Inc. buyer in Q2 2021 was Rubric Capital Management (New York), an estimated $9.91M added.
  • The largest Radius Health, Inc. seller in Q2 2021 was Wellington Management Group, an estimated $6.59M sold.

Based on aggregated 13F filings for Q2 2021.